Results: 3

    Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

    J Antimicrob Chemother; 71 (11), 2016
    BACKGROUND: Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin. OBJECTI...

    Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric)

    Intensive care med; 41 (7), 2015
    Emerging resistance to antibiotics shows no signs of decline. At the same time, few new antibacterials are being discovered. There is a worldwide recognition regarding the danger of this situation. The urgency of the situation and the conviction that practices should change led the Société de Réanimat...

    Guideline: managing possible serious bacterial infection in young infants when referral is not feasible

    Infections are responsible for about one fifth of the world’s annual 2.7 million neonatal deaths. In South Asia and sub-Saharan Africa about one quarter of all neonatal deaths are due to infections. Many sick infants only have non-specific signs, and thus are not recognized to have infection. Even when...